A.S.P.E.N. Clinical guidelines: Nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation

Journal of Parenteral and Enteral Nutrition

Volumn 33, Issue 5, 2009, Pages 472-500

  August, David Allen ^a,b,d   Huhmann, Maureen B ^c  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; OMEGA 3 FATTY ACID; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; ALTERNATIVE MEDICINE; ANOREXIA; BLADDER CANCER; BREAST CANCER; CACHEXIA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PREVENTION; CLINICAL TRIAL; COLORECTAL CANCER; DIET SUPPLEMENTATION; DIET THERAPY; DIGESTIVE SYSTEM CANCER; ENTERIC FEEDING; ESOPHAGUS CANCER; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; INTESTINE OBSTRUCTION; LARYNX CANCER; LUNG METASTASIS; LUNG SMALL CELL CANCER; LYMPHOMA; MALNUTRITION; MUCOSA INFLAMMATION; NUTRITIONAL SUPPORT; PANCREAS CANCER; PARENTERAL NUTRITION; PRIORITY JOURNAL; RADIATION ENTEROPATHY; REVIEW;

ADULT; ANTINEOPLASTIC AGENTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALNUTRITION; MEDLINE; NEOPLASMS; NUTRITIONAL SUPPORT; PALLIATIVE CARE; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WEIGHT LOSS;

EID: 69949108830     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607109341804     Document Type: Review

References (184)

1. Inagaki J., Rodriguez V., Bodey GP Proceedings: causes of death in cancer patients. Cancer. 1974 ; 33 (2). 568-573.
2. Kern KA, Norton JA Cancer cachexia. JPEN J Parenter Enteral Nutr. 1988 ; 12 (3). 286-298.
3. Dewys WD, Begg C., Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980 ; 69 (4). 491-497.
4. Bosaeus I., Daneryd P., Svanberg E., Lundholm K. Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer. 2001 ; 93 (3). 380-383.
5. Bosaeus I., Daneryd P., Lundholm K. Dietary intake, resting energy expenditure, weight loss and survival in cancer patients. J Nutr. 2002 ; 132 (11 suppl). 3465S - 3466S.
6. Puccio M., Nathanson L. The cancer cachexia syndrome. Semin Oncol. 1997 ; 24 (3). 277-287.
7. Ottery FD Supportive nutrition to prevent cachexia and improve quality of life. Semin Oncol. 1995 ; 22 (2 suppl 3). 98-111.
8. Bozzetti F. Rationale and indications for preoperative feeding of malnourished surgical cancer patients. Nutrition. 2002 ; 18 (11-12). 953-959.
9. Koretz RL Do data support nutrition support? Part I: intravenous nutrition. J Am Diet Assoc. 2007 ; 107 (6). 988-996 ; quiz 998.
10. McGeer A., Detsky A., O'Rourke K. Parenteral nutrition in cancer patients undergoing chemotherapy: a meta-analysis. Nutrition. 1990 ; 6 (3). 233-240.
11. Goldstein SA, Elwyn DH, Askanazi J. Functional and metabolic changes during feeding in gastrointestinal cancer. J Am Coll Nutr. 1989 ; 8 (6). 530-536.
12. Torosian MH Stimulation of tumor growth by nutrition support. JPEN J Parenter Enteral Nutr. 1992 ; 16 (6 suppl). 72S - 75S.
13. Baron PL, Lawrence W. Jr, Chan WM, White FK, Banks WL Jr. Effects of parenteral nutrition on cell cycle kinetics of head and neck cancer. Arch Surg. 1986 ; 121 (11). 1282-1286.
14. Frank JL, Lawrence W. Jr, Banks WL Jr, McKinnon JG, Chan WM, Collins JM Modulation of cell cycle kinetics in human cancer with total parenteral nutrition. Cancer. 1992 ; 69 (7). 1858-1864.
15. Franchi F., Rossi-Fanelli F., Seminara P., Cascino A., Barone C., Scucchi L. Cell kinetics of gastrointestinal tumors after different nutritional regimens. A preliminary report. J Clin Gastroenterol. 1991 ; 13 (3). 313-315.
16. Heys SD, Park KG, McNurlan MA, et al. Stimulation of protein synthesis in human tumours by parenteral nutrition: evidence for modulation of tumour growth. Br J Surg. 1991 ; 78 (4). 483-487.
17. Bozzetti F., Gavazzi C., Mariani L., Crippa F. Glucose-based total parenteral nutrition does not stimulate glucose uptake by humans tumours. Clin Nutr. 2004 ; 23 (3). 417-421.
18. Pacelli F., Bossola M., Teodori L., et al. Parenteral nutrition does not stimulate tumor proliferation in malnourished gastric cancer patients. JPEN J Parenter Enteral Nutr. 2007 ; 31 (6). 451-455.
19. A.S.P.E.N. Board of Directors. Guidelines for use of total parenteral nutrition in the hospitalized adult patient. JPEN J Parenter Enteral Nutr. 1986 ; 10 (5). 441-445.
20. A.S.P.E.N. Board of Directors. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 1993 ; 17 (4 suppl). 1SA - 52SA.
21. A.S.P.E.N. Board of Directors and The Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients [erratum in JPEN 2002;26(2):144]. JPEN J Parenter Enteral Nutr. 2002 ; 26 (1 suppl). 1SA - 138SA.
22. Committee to Advise the Public Health Service on Clinical Practice Guidelines, Institute of Medicine. Field MJ, Lohr KN, eds. Clinical Practice Guidelines: Directions for a New Program. Washington, DC: The National Academies Press ; 1990: 58.
23. Seres D., Compher C., Seidner D., Byham-Gray L., Gervasio J., McClave S. 2005 American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Standards and Guidelines survey. Nutr Clin Pract. 2006 ; 21 (5). 529-532.
24. Dellinger RP, Carlet JM, Masur H., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004 ; 32 (3). 858-873.
25. Guyatt GH, Haynes RB, Jaeschke RZ, et al. for the Evidence-Based Medicine Working Group. Users' Guides to the Medical Literature: XXV. Evidence-based medicine: principles for applying the Users' Guides to patient care. JAMA. 2000 ; 284 (10). 1290-1296.
26. Bauer J., Capra S. Comparison of a malnutrition screening tool with subjective global assessment in hospitalised patients with cancer-sensitivity and specificity. Asia Pac J Clin Nutr. 2003 ; 12 (3). 257-260.
27. Bauer J., Capra S., Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr. 2002 ; 56 (8). 779-785.
28. Read JA, Crockett N., Volker DH, et al. Nutritional assessment in cancer: comparing the Mini-Nutritional Assessment (MNA) with the scored Patient-Generated Subjective Global Assessment (PGSGA). Nutr Cancer. 2005 ; 53 (1). 51-56.
29. Sarhill N., Mahmoud F., Walsh D., et al. Evaluation of nutritional status in advanced metastatic cancer. Support Care Cancer. 2003 ; 11 (10). 652-659. (Pubitemid 37243596)
30. Sungurtekin H., Sungurtekin U., Hanci V., Erdem E. Comparison of two nutrition assessment techniques in hospitalized patients. Nutrition. 2004 ; 20 (5). 428-432.
31. Unsal D., Mentes B., Akmansu M., Uner A., Oguz M., Pak Y. Evaluation of nutritional status in cancer patients receiving radiotherapy: a prospective study. Am J Clin Oncol. 2006 ; 29 (2). 183-188.
32. van Bokhorst-de van der Schueren MA, van Leeuwen PA, Sauerwein HP, Kuik DJ, Snow GB, Quak JJ Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complications. Head Neck. 1997 ; 19 (5). 419-425.
33. Murry DJ, Riva L., Poplack DG Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl. 1998 ; 11: 48-51.
34. Hammerlid E., Wirblad B., Sandin C., et al. Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head Neck. 1998 ; 20 (6). 540-548.
35. Isenring E., Bauer J., Capra S. The effect of intensive dietetic intervention on nutritional status of hospitalized patients on chemotherapy. Nutrition and Dietetics. 2004 ; 61: 46-49.
36. Isenring E., Capra S., Bauer J. Patient satisfaction is rated higher by radiation oncology outpatients receiving nutrition intervention compared with usual care. J Hum Nutr Diet. 2004 ; 17 (2). 145-152.
37. Piquet MA, Ozsahin M., Larpin I., et al. Early nutritional intervention in oropharyngeal cancer patients undergoing radiotherapy. Support Care Cancer. 2002 ; 10 (6). 502-504.
38. Ravasco P., Monteiro-Grillo I., Vidal PM, Camilo ME Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol. 2005 ; 23 (7). 1431-1438. (Pubitemid 46260030)
39. Ferguson ML, Bauer J., Gallagher B., Capra S., Christie DR, Mason BR Validation of a malnutrition screening tool for patients receiving radiotherapy. Australas Radiol. 1999 ; 43 (3). 325-327.
40. Isenring E., Cross G., Daniels L., Kellett E., Koczwara B. Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy. Support Care Cancer. 2006 ; 14 (11). 1152-1156.
41. Holter AR, Fischer JE The effects of perioperative hyperalimentation on complications in patients with carcinoma and weight loss. J Surg Res. 1977 ; 23 (1). 31-34.
42. Sako K., Lore JM, Kaufman S., Razack MS, Bakamjian V., Reese P. Parenteral hyperalimentation in surgical patients with head and neck cancer: a randomized study. J Surg Oncol. 1981 ; 16 (4). 391-402.
43. Muller JM, Brenner U., Dienst C., Pichlmaier H. Preoperative parenteral feeding in patients with gastrointestinal carcinoma. Lancet. 1982 ; 1 (8263). 68-71.
44. Yamada N., Koyama H., Hioki K., Yamada T., Yamamoto M. Effect of postoperative total parenteral nutrition (TPN) as an adjunct to gastrectomy for advanced gastric carcinoma. Br J Surg. 1983 ; 70 (5). 267-274.
45. Muller JM, Keller HW, Brenner U., Walter M., Holzmuller W. Indications and effects of preoperative parenteral nutrition. World J Surg. 1986 ; 10 (1). 53-63.
46. Perioperative total parenteral nutrition in surgical patients. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. N Engl J Med. 1991 ; 325 (8). 525-532.
47. Brennan MF, Pisters PW, Posner M., Quesada O., Shike M. A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann Surg. 1994 ; 220 (4). 436-441 ; discussion 441-434.
48. Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med. 1994 ; 331 (23). 1547-1552.
49. Bozzetti F., Gavazzi C., Miceli R., et al. Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial. JPEN J Parenter Enteral Nutr. 2000 ; 24 (1). 7-14.
50. Hyltander A., Bosaeus I., Svedlund J., et al. Supportive nutrition on recovery of metabolism, nutritional state, health-related quality of life, and exercise capacity after major surgery: a randomized study. Clin Gastroenterol Hepatol. 2005 ; 3 (5). 466-474.
51. Wu GH, Liu ZH, Wu ZH, Wu ZG Perioperative artificial nutrition in malnourished gastrointestinal cancer patients. World J Gastroenterol. 2006 ; 12 (15). 2441-2444.
52. Meijerink WJ, von Meyenfeldt MF, Rouflart MM, Soeters PB Efficacy of perioperative nutritional support. Lancet. 1992 ; 340 (8812). 187-188.
53. Gianotti L., Braga M., Vignali A., et al. Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms. Arch Surg. 1997 ; 132 (11). 1222-1229 ; discussion 1229-1230.
54. Sand J., Luostarinen M., Matikainen M. Enteral or parenteral feeding after total gastrectomy: prospective randomised pilot study. Eur J Surg. 1997 ; 163 (10). 761-766.
55. Shirabe K., Matsumata T., Shimada M., et al. A comparison of parenteral hyperalimentation and early enteral feeding regarding systemic immunity after major hepatic resection-the results of a randomized prospective study. Hepatogastroenterology. 1997 ; 44 (13). 205-209.
56. Braga M., Gianotti L., Gentilini O., Parisi V., Salis C., Di Carlo V. Early postoperative enteral nutrition improves gut oxygenation and reduces costs compared with total parenteral nutrition. Crit Care Med. 2001 ; 29 (2). 242-248.
57. Bozzetti F., Braga M., Gianotti L., Gavazzi C., Mariani L. Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial. Lancet. 2001 ; 358 (9292). 1487-1492.
58. Aiko S., Yoshizumi Y., Sugiura Y., et al. Beneficial effects of immediate enteral nutrition after esophageal cancer surgery. Surg Today. 2001 ; 31 (11). 971-978.
59. Papapietro K., Diaz E., Csendes A., et al. Early enteral nutrition in cancer patients subjected to a total gastrectomy. Rev Med Chil. 2002 ; 130 (10). 1125-1130.
60. Jiang XH, Li N., Li JS Intestinal permeability in patients after surgical trauma and effect of enteral nutrition versus parenteral nutrition. World J Gastroenterol. 2003 ; 9 (8). 1878-1880.
61. Aiko S., Yoshizumi Y., Matsuyama T., Sugiura Y., Maehara T. Influences of thoracic duct blockage on early enteral nutrition for patients who underwent esophageal cancer surgery. Jpn J Thorac Cardiovasc Surg. 2003 ; 51 (7). 263-271.
62. Hu QG, Zheng QC The influence of enteral nutrition in postoperative patients with poor liver function. World J Gastroenterol. 2003 ; 9 (4). 843-846.
63. Goonetilleke KS, Siriwardena AK Systematic review of perioperative nutritional supplementation in patients undergoing pancreaticoduodenectomy. JOP. 2006 ; 7 (1). 5-13.
64. Hyltander A., Drott C., Unsgaard B., et al. The effect on body composition and exercise performance of home parenteral nutrition when given as adjunct to chemotherapy of testicular carcinoma. Eur J Clin Invest. 1991 ; 21 (4). 413-420.
65. Sagar S., Harland P., Shields R. Early postoperative feeding with elemental diet. Br Med J. 1979 ; 1 (6159). 293-295.
66. Smith RC, Hartemink RJ, Hollinshead JW, Gillett DJ Fine bore jejunostomy feeding following major abdominal surgery: a controlled randomized clinical trial. Br J Surg. 1985 ; 72 (6). 458-461.
67. Foschi D., Cavagna G., Callioni F., Morandi E., Rovati V. Hyperalimentation of jaundiced patients on percutaneous transhepatic biliary drainage. Br J Surg. 1986 ; 73 (9). 716-719.
68. Heslin MJ, Latkany L., Leung D., et al. A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg. 1997 ; 226 (4). 567-577 ; discussion 577-580.
69. Seven H., Calis AB, Turgut S. A randomized controlled trial of early oral feeding in laryngectomized patients. Laryngoscope. 2003 ; 113 (6). 1076-1079.
70. Jordan WM, Valdivieso M., Frankmann C., et al. Treatment of advanced adenocarcinoma of the lung with ftorafur, doxorubicin, cyclophosphamide, and cisplatin (FACP) and intensive iv hyperalimentation. Cancer Treat Rep. 1981 ; 65 (3-4). 197-205.
71. Nixon D., Moffitt S., Lawson D., et al. Total parenteral nutrition as an adjunct to chemotherapy for metastatic colorectal cancer. Cancer Treatment Reports. 1981 ; 65 (suppl 5). 123-128.
72. Popp MB, Fisher RI, Wesley R., Aamodt R., Brennan MF A prospective randomized study of adjuvant parenteral nutrition in the treatment of advanced diffuse lymphoma: influence on survival. Surgery. 1981 ; 90 (2). 195-203.
73. Samuels ML, Selig DE, Ogden S., Grant C., Brown B. Iv hyperalimentation and chemotherapy for stage III testicular cancer: a randomized study. Cancer Treat Rep. 1981 ; 65 (7-8). 615-627.
74. Serrou B., Cupissol D., Plagne R., et al. Follow-up of a randomized trial for oat cell carcinoma evaluating the efficacy of peripheral intravenous nutrition (PIVN) as adjunct treatment. Recent Results Cancer Res. 1982 ; 80: 246-253.
75. Shamberger RC, Brennan MF, Goodgame JT Jr, et al. A prospective, randomized study of adjuvant parenteral nutrition in the treatment of sarcomas: results of metabolic and survival studies. Surgery. 1984 ; 96 (1). 1-13.
76. Tandon SP, Gupta SC, Sinha SN, Naithani YP Nutritional support as an adjunct therapy of advanced cancer patients. Indian J Med Res. 1984 ; 80: 180-188.
77. Clamon GH, Feld R., Evans WK, et al. Effect of adjuvant central IV hyperalimentation on the survival and response to treatment of patients with small cell lung cancer: a randomized trial. Cancer Treat Rep. 1985 ; 69 (2). 167-177.
78. Valdivieso M., Frankmann C., Murphy WK, et al. Long-term effects of intravenous hyperalimentation administered during intensive chemotherapy for small cell bronchogenic carcinoma. Cancer. 1987 ; 59 (2). 362-369.
79. Evans WK, Nixon DW, Daly JM, et al. A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J Clin Oncol. 1987 ; 5 (1). 113-124.
80. De Cicco M., Panarello G., Fantin D., et al. Parenteral nutrition in cancer patients receiving chemotherapy: effects on toxicity and nutritional status. JPEN J Parenter Enteral Nutr. 1993 ; 17 (6). 513-518.
81. Bozzetti F., Cozzaglio L., Gavazzi C., et al. Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survival. Tumori. 1998 ; 84 (6). 681-686.
82. Jin D., Phillips M., Byles JE Effects of parenteral nutrition support and chemotherapy on the phasic composition of tumor cells in gastrointestinal cancer. JPEN J Parenter Enteral Nutr. 1999 ; 23 (4). 237-241.
83. Beer KT, Krause KB, Zuercher T., Stanga Z. Early percutaneous endoscopic gastrostomy insertion maintains nutritional state in patients with aerodigestive tract cancer. Nutr Cancer. 2005 ; 52 (1). 29-34.
84. Mangar S., Slevin N., Mais K., Sykes A. Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: a retrospective review. Radiother Oncol. 2006 ; 78 (2). 152-158.
85. Rabinovitch R., Grant B., Berkey BA, et al. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03. Head Neck. 2006 ; 28 (4). 287-296.
86. Scolapio JS, Tarrosa VB, Stoner GL, Moreno-Aspitia A., Solberg LA Jr, Atkinson EJ Audit of nutrition support for hematopoietic stem cell transplantation at a single institution. Mayo Clin Proc. 2002 ; 77 (7). 654-659.
87. Gavazzi C., Bhoori S., Lovullo S., Cozzi G., Mariani L. Role of home parenteral nutrition in chronic radiation enteritis. Am J Gastroenterol. 2006 ; 101 (2). 374-379.
88. Bachmann P., Marti-Massoud C., Blanc-Vincent MP, et al. Summary version of the Standards, Options and Recommendations for palliative or terminal nutrition in adults with progressive cancer (2001). Br J Cancer. 2003 ; 89 (suppl 1). S107 - S110.
89. Abu-Rustum NR, Barakat RR, Venkatraman E., Spriggs D. Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecol Oncol. 1997 ; 64 (3). 493-495.
90. August DA, Thorn D., Fisher RL, Welchek CM Home parenteral nutrition for patients with inoperable malignant bowel obstruction. JPEN J Parenter Enteral Nutr. 1991 ; 15 (3). 323-327.
91. King LA, Carson LF, Konstantinides N., et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience ? Gynecol Oncol. 1993 ; 51 (3). 377-382.
92. Lundholm K., Daneryd P., Bosaeus I., Korner U., Lindholm E. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function. Cancer. 2004 ; 100 (9). 1967-1977.
93. McCann RM, Hall WJ, Groth-Juncker A. Comfort care for terminally ill patients: the appropriate use of nutrition and hydration. JAMA. 1994 ; 272 (16). 1263-1266.
94. Orrevall Y., Tishelman C., Permert J. Home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families. Clin Nutr. 2005 ; 24 (6). 961-970.
95. Scolapio JS, Fleming CR, Kelly DG, Wick DM, Zinsmeister AR Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic. Mayo Clin Proc. 1999 ; 74 (3). 217-222.
96. Brard L., Weitzen S., Strubel-Lagan SL, et al. The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients. Gynecol Oncol. 2006 ; 103 (1). 176-180.
97. Mirhosseini N., Fainsinger RL, Baracos V. Parenteral nutrition in advanced cancer: indications and clinical practice guidelines. J Palliat Med. 2005 ; 8 (5). 914-918.
98. Baines M., Oliver DJ, Carter RL Medical management of intestinal obstruction in patients with advanced malignant disease: a clinical and pathological study. Lancet. 1985 ; 2 (8462). 990-993.
99. Welk TA Clinical and ethical considerations of fluid and electrolyte management in the terminally ill client. J Intraven Nurs. 1999 ; 22 (1). 43-47.
100. Jho DH, Cole SM, Lee EM, Espat NJ Role of omega-3 fatty acid supplementation in inflammation and malignancy. Integr Cancer Ther. 2004 ; 3 (2). 98-111.
101. Hardman WE Omega-3 fatty acids to augment cancer therapy. J Nutr. 2002 ; 132 (11 suppl). 3508S - 3512S.
102. Wigmore SJ, Ross JA, Falconer JS, et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition. 1996 ; 12 (1 suppl). S27 - S30.
103. Gogos CA, Ginopoulos P., Salsa B., Apostolidou E., Zoumbos NC, Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer. 1998 ; 82 (2). 395-402.
104. Burns CP, Halabi S., Clamon GH, et al. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473. Clin Cancer Res. 1999 ; 5 (12). 3942-3947.
105. Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KC Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer. 2000 ; 36 (2). 177-184.
106. Bruera E., Strasser F., Palmer JL, et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/ cachexia: a double-blind, placebo-controlled study. J Clin Oncol. 2003 ; 21 (1). 129-134.
107. Gogos CA, Ginopoulos P., Zoumbos NC, Apostolidou E., Kalfarentzos F. The effect of dietary omega-3 polyunsaturated fatty acids on T-lymphocyte subsets of patients with solid tumors. Cancer Detect Prev. 1995 ; 19 (5). 415-417.
108. Barber MD, Ross JA, Preston T., Shenkin A., Fearon KC Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. J Nutr. 1999 ; 129 (6). 1120-1125.
109. Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KC The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer. 1999 ; 81 (1). 80-86.
110. Barber MD, Fearon KC, Tisdale MJ, McMillan DC, Ross JA Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer. 2001 ; 40 (2). 118-124.
111. Bauer J., Capra S., Battistutta D., Davidson W., Ash S. Compliance with nutrition prescription improves outcomes in patients with unresectable pancreatic cancer. Clin Nutr. 2005 ; 24 (6). 998-1004.
112. Fearon KC, Von Meyenfeldt MF, Moses AG, et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003 ; 52 (10). 1479-1486.
113. Jatoi A., Rowland K., Loprinzi CL, et al. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol. 2004 ; 22 (12). 2469-2476.
114. Mantovani G., Madeddu C., Maccio A., et al. Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment. Cancer Epidemiol Biomarkers Prev. 2004 ; 13 (10). 1651-1659.
115. de Luis DA, Izaola O., Aller R., Cuellar L., Terroba MC A randomized clinical trial with oral Immunonutrition (omega3-enhanced formula vs. arginine-enhanced formula) in ambulatory head and neck cancer patients. Ann Nutr Metab. 2005 ; 49 (2). 95-99.
116. Moses AW, Slater C., Preston T., Barber MD, Fearon KC Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer. 2004 ; 90 (5). 996-1002.
117. Persson C., Glimelius B., Ronnelid J., Nygren P. Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study. Nutrition. 2005 ; 21 (2). 170-178.
118. Carter JP, Saxe GP, Newbold V., Peres CE, Campeau RJ, Bernal-Green L. Hypothesis: dietary management may improve survival from nutritionally linked cancers based on analysis of representative cases. J Am Coll Nutr. 1993 ; 12 (3). 209-226.
119. Gonzalez NJ, Isaacs LL Evaluation of pancreatic proteolytic enzyme treatment of adenocarcinoma of the pancreas, with nutrition and detoxification support. Nutr Cancer. 1999 ; 33 (2). 117-124.
120. Hildenbrand GL, Hildenbrand LC, Bradford K., Cavin SW Five-year survival rates of melanoma patients treated by diet therapy after the manner of Gerson: a retrospective review. Altern Ther Health Med. 1995 ; 1 (4). 29-37.
121. Braga M., Gianotti L., Vignali A., Carlo VD Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery. 2002 ; 132 (5). 805-814.
122. Braga M., Gianotti L., Vignali A., Cestari A., Bisagni P., Di Carlo V. Artificial nutrition after major abdominal surgery: impact of route of administration and composition of the diet. Crit Care Med. 1998 ; 26 (1). 24-30.
123. Daly JM, Lieberman MD, Goldfine J., et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery. 1992 ; 112 (1). 56-67.
124. Daly JM, Weintraub FN, Shou J., Rosato EF, Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg. 1995 ; 221 (4). 327-338.
125. Di Carlo V., Gianotti L., Balzano G., Zerbi A., Braga M. Complications of pancreatic surgery and the role of perioperative nutrition. Dig Surg. 1999 ; 16 (4). 320-326.
126. Farreras N., Artigas V., Cardona D., Rius X., Trias M., Gonzalez JA Effect of early postoperative enteral immunonutrition on wound healing in patients undergoing surgery for gastric cancer. Clin Nutr. 2005 ; 24 (1). 55-65.
127. Gianotti L., Braga M., Nespoli L., Radaelli G., Beneduce A., Di Carlo V. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology. 2002 ; 122 (7). 1763-1770.
128. Senkal M., Zumtobel V., Bauer KH, et al. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg. 1999 ; 134 (12). 1309-1316.
129. Braga M., Gianotti L., Nespoli L., Radaelli G., Di Carlo V. Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg. 2002 ; 137 (2). 174-180.
130. Moore FA Effects of immune-enhancing diets on infectious morbidity and multiple organ failure. JPEN J Parenter Enteral Nutr. 2001 ; 25 (2 suppl). S36 - S42 ; discussion S42 - S43.
131. de Luis DA, Izaola O., Cuellar L., Terroba MC, Aller R. Randomized clinical trial with an enteral arginine-enhanced formula in early postsurgical head and neck cancer patients. Eur J Clin Nutr. 2004 ; 58 (11). 1505-1508.
132. Morlion BJ, Stehle P., Wachtler P., et al. Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: a randomized, double-blind, controlled study. Ann Surg. 1998 ; 227 (2). 302-308.
133. van Bokhorst-De Van Der Schueren MA, Quak JJ, von Blomberg-van der Flier BM, et al. Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients. Am J Clin Nutr. 2001 ; 73 (2). 323-332.
134. Thomas E, Blume K, Forman S, eds. Hematopoietic Cell Transplantation. 2 nd ed. Malden, MA: Blackwell Science ; 1999.
135. Deeg HJ, Seidel K., Bruemmer B., Pepe MS, Appelbaum FR Impact of patient weight on non-relapse mortality after marrow transplantation. Bone Marrow Transplant. 1995 ; 15 (3). 461-468.
136. McSweeney PA, Storb R. Mixed chimerism: preclinical studies and clinical applications. Biol Blood Marrow Transplant. 1999 ; 5 (4). 192-203.
137. Bensinger W., Buckner C. Preparative regimens. In: Thomas E, Blume K, Forman S, eds. Hematopoietic Cell Transplantation. Malden, MA: Blackwell Science ; 1999: 123-134.
138. Aker S., Lessen P. Nutritional support in hematological malignancies. In: Hoffman R, Benz E, Shattil S, et al, eds. Hematology: Basic principles and practice. 3 rd ed. New York, NY: Churchill Livingstone ; 2000: 1501-1514.
139. Lenssen P., Sherry ME, Cheney CL, et al. Prevalence of nutrition-related problems among long-term survivors of allogeneic marrow transplantation. J Am Diet Assoc. 1990 ; 90 (6). 835-842.
140. Dickson TM, Kusnierz-Glaz CR, Blume KG, et al. Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation. Biol Blood Marrow Transplant. 1999 ; 5 (5). 299-305.
141. Fleming DR, Rayens MK, Garrison J. Impact of obesity on allogeneic stem cell transplant patients: a matched case-controlled study. Am J Med. 1997 ; 102 (3). 265-268.
142. Morton AJ, Gooley T., Hansen JA, et al. Association between pre-transplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase. Blood. 1998 ; 92 (2). 394-401.
143. Horsley P., Bauer J., Gallagher B. Poor nutritional status prior to peripheral blood stem cell transplantation is associated with increased length of hospital stay. Bone Marrow Transplant. 2005 ; 35 (11). 1113-1116.
144. Iestra JA, Fibbe WE, Zwinderman AH, van Staveren WA, Kromhout D. Body weight recovery, eating difficulties and compliance with dietary advice in the first year after stem cell transplantation: a prospective study. Bone Marrow Transplant. 2002 ; 29 (5). 417-424.
145. Layton PB, Gallucci BB, Aker SN Nutritional assessment of allogeneic bone marrow recipients. Cancer Nurs. 1981 ; 4 (2). 127-134.
146. Lough M., Watkins R., Campbell M., Carr K., Burnett A., Shenkin A. Parenteral nutrition in bone marrow transplantation. Clin Nutr. 1990 ; 9 (2). 97-101.
147. Roberts S., Miller J., Pineiro L., Jennings L. Total parenteral nutrition vs oral diet in autologous hematopoietic cell transplant recipients. Bone Marrow Transplant. 2003 ; 32 (7). 715-721.
148. Skop A., Kolarzyk E., Skotnicki AB Importance of parenteral nutrition in patients undergoing hemopoietic stem cell transplantation procedures in the autologous system. JPEN J Parenter Enteral Nutr. 2005 ; 29 (4). 241-247.
149. Cetin T., Arpaci F., Dere Y., et al. Total parenteral nutrition delays platelet engraftment in patients who undergo autologous hematopoietic stem cell transplantation. Nutrition. 2002 ; 18 (7-8). 599-603.
150. Mulder PO, Bouman JG, Gietema JA, et al. Hyperalimentation in autologous bone marrow transplantation for solid tumors. Comparison of total parenteral versus partial parenteral plus enteral nutrition. Cancer. 1989 ; 64 (10). 2045-2052.
151. Sheean PM, Braunschweig C., Rich E. The incidence of hyperglycemia in hematopoietic stem cell transplant recipients receiving total parenteral nutrition: a pilot study. J Am Diet Assoc. 2004 ; 104 (9). 1352-1360.
152. Sheean PM, Freels SA, Helton WS, Braunschweig CA Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006 ; 12 (6). 656-664.
153. Charuhas PM, Fosberg KL, Bruemmer B., et al. A double-blind randomized trial comparing outpatient parenteral nutrition with intravenous hydration: effect on resumption of oral intake after marrow transplantation. JPEN J Parenter Enteral Nutr. 1997 ; 21 (3). 157-161.
154. Jonas CR, Puckett AB, Jones DP, et al. Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr. 2000 ; 72 (1). 181-189.
155. Weisdorf SA, Lysne J., Wind D., et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation. 1987 ; 43 (6). 833-838.
156. Geibig CB, Owens JP, Mirtallo JM, Bowers D., Nahikian-Nelms M., Tutschka P. Parenteral nutrition for marrow transplant recipients: evaluation of an increased nitrogen dose. JPEN J Parenter Enteral Nutr. 1991 ; 15 (2). 184-188.
157. Muscaritoli M., Conversano L., Torelli GF, et al. Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation. Transplantation. 1998 ; 66 (5). 610-616.
158. Szeluga DJ, Stuart RK, Brookmeyer R., Utermohlen V., Santos GW Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res. 1987 ; 47 (12). 3309-3316.
159. Sefcick A., Anderton D., Byrne JL, Teahon K., Russell NH Naso-jejunal feeding in allogeneic bone marrow transplant recipients: results of a pilot study. Bone Marrow Transplant. 2001 ; 28 (12). 1135-1139.
160. Seguy D., Berthon C., Micol JB, et al. Enteral feeding and early outcomes of patients undergoing allogeneic stem cell transplantation following myeloablative conditioning. Transplantation. 2006 ; 82 (6). 835-839.
161. Lenssen P., Bruemmer B., Aker SN, McDonald GB Nutrient support in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr. 2001 ; 25 (4). 219-228.
162. Anderson PM, Ramsay NK, Shu XO, et al. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant. 1998 ; 22 (4). 339-344.
163. Coghlin Dickson TM, Wong RM, offrin RS, et al. Effect of oral glutamine supplementation during bone marrow transplantation. JPEN J Parenter Enteral Nutr. 2000 ; 24 (2). 61-66.
164. Jebb SA, Marcus R., Elia M. A pilot study of oral glutamine supplementation in patients receiving bone marrow transplants. Clin Nutr. 1995 ; 14 (3). 162-165.
165. Schloerb PR, Skikne BS Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study. JPEN J Parenter Enteral Nutr. 1999 ; 23 (3). 117-122.
166. Piccirillo N., De Matteis S., Laurenti L., et al. Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis. Haematologica. 2003 ; 88 (2). 192-200.
167. Pytlik R., Benes P., Patorkova M., et al. Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study. Bone Marrow Transplant. 2002 ; 30 (12). 953-961.
168. Scheid C., Hermann K., Kremer G., et al. Randomized, double-blind, controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of patients with acute leukemia undergoing intensive chemotherapy. Nutrition. 2004 ; 20 (3). 249-254.
169. Schloerb PR, Amare M. Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study). JPEN J Parenter Enteral Nutr. 1993 ; 17 (5). 407-413.
170. Sykorova A., Horacek J., Zak P., Kmonicek M., Bukac J., Maly J. A randomized, double blind comparative study of prophylactic parenteral nutritional support with or without glutamine in autologous stem cell transplantation for hematological malignancies- three years' follow-up. Neoplasma. 2005 ; 52 (6). 476-482.
171. Young LS, Bye R., Scheltinga M., Ziegler TR, Jacobs DO, Wilmore DW Patients receiving glutamine-supplemented intravenous feedings report an improvement in mood. JPEN J Parenter Enteral Nutr. 1993 ; 17 (5). 422-427.
172. Ziegler TR, Young LS, Benfell K., et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med. 1992 ; 116 (10). 821-828.
173. Murray SM, Pindoria S. Nutrition support for bone marrow transplant patients. Cochrane Database Syst Rev. 2009 (1). CD002920.
174. Bodey GP, Hart J., Freireich EJ, Frei E. III. Studies of a patient isolator unit and prophylactic antibiotics in cancer chemotherapy. General techniques and preliminary results. Cancer. 1968 ; 22 (5). 1018-1026.
175. Bodey GP, Loftis J., Bowen E. Protected environment for cancer patients: effect of a prophylactic antibiotic regimen on the microbial flora of patients undergoing cancer chemotherapy. Arch Intern Med. 1968 ; 122 (1). 23-30.
176. Dietrich M., Gaus W., Vossen J., van der Waaij D., Wendt F. Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection: a prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results. Infection. 1977 ; 5 (2). 107-114.
177. Levine AS, Siegel SE, Schreiber AD, et al. Protected environments and prophylactic antibiotics: a prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med. 1973 ; 288 (10). 477-483.
178. Levitan AA, Perry S. Infectious complications of chemotherapy in a protected environment. N Engl J Med. 1967 ; 276 (16). 881-886.
179. Moody K., Charlson ME, Finlay J. The neutropenic diet: what's the evidence ? J Pediatr Hematol Oncol. 2002 ; 24 (9). 717-721.
180. Yates JW, Holland JF A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients. Cancer. 1973 ; 32 (6). 1490-1498.
181. Smith LH, Besser SG Dietary restrictions for patients with neutropenia: a survey of institutional practices. Oncol Nurs Forum. 2000 ; 27 (3). 515-520.
182. Moody K., Finlay J., Mancuso C., Charlson M. Feasibility and safety of a pilot randomized trial of infection rate: neutropenic diet versus standard food safety guidelines. J Pediatr Hematol Oncol. 2006 ; 28 (3). 126-133.
183. Gardner A., Mattiuzzi G., Faderl S., et al. Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia. J Clin Oncol. 2008 ; 26 (35). 5684-5688.
184. Cheney CL, Weiss NS, Fisher LD, Sanders JE, Davis S., Worthington-Roberts B. Oral protein intake and the risk of acute graft-versus-host disease after allogeneic marrow transplantation. Bone Marrow Transplant. 1991 ; 8 (3). 203-210.